Shunchong
1
5M
1
1
- Areas of investment
Summary
The leading representative office of defined Corporate Investor is situated in the Hangzhou. The venture was found in Asia in China.
Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Pet City. We can highlight the next thriving fund investment areas, such as Medical Device, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - China.
The standard case for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are Pure Funds.
Deals in the range of 5 - 10 millions dollars are the general things for fund. The top activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 1
- Investments by industry
- Health Care (1)
- Health Diagnostics (1)
- Medical Device (1)
- Investments by region
-
- China (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 4
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Pet City | 27 Jul 2018 | Health Care, Health Diagnostics, Medical Device | Seed | 5M | Zhejiang, Shangcheng District, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.